Sizmek Inc.

(SZMK) Trade

By |

Profile

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 203 533-7082
Address: 14 Water Street
Address 2: P.O. Box 64
State: CT
City / Town: Guilford
Country: US
Postal Code: 06437

Issuer Information

Exchange: NGS
CEO: Deborah Ann Rathjen
Employees: 1204
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological disease and disorders. The company has worked on blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier. Its source of revenue involves the research and license revenue.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 203 533-7082
Address: 14 Water Street
Address 2: P.O. Box 64
State: CT
City / Town: Guilford
Country: US
Postal Code: 06437

Issuer Information

Exchange: NGS
CEO: Deborah Ann Rathjen
Employees: 1204
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 3.90 $ 0. (0.00%)
Last Price 3.90 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 3.90
Last Trade Volume 0 52 Wk Hi 6.77 52 Wk Low 2.09
Market Cap 264.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 67,963,256.00 EPS (TTM) -0.05 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.9 3.9 3.9 3.9
Low Target Price Estimate 3.9 3.9 3.9 3.9
Mean Target Price Estimate 3.9 3.9 3.9 3.9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/03/16 08/03/16 08/03/16 08/03/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 3 3 3